Neidhardt M, Habermalz H J, Henze G, Langermann H J
Klin Padiatr. 1982 Jul-Aug;194(4):257-61. doi: 10.1055/s-2008-1033814.
The principle of giving intensive polychemotherapy in the time between operation and irradiation was applied in a cooperative phase-2-study in children with medulloblastoma of the posterior fossa. A first evaluation of 33 of 47 registered patients was attempted after the study existing now for 1 year and 10 months. In the majority of patients the chemotherapy protocol could be fully realized without any deductions. Side effects including two therapy related fatalities were analysed. In all patients irradiation was not delayed and could be started about 11 weeks after operation and could be carried through without any major draw-backs. Analysis of survival can only be preliminary due to the short duration of the study, but patients' survival is compatible with other reported studies. The therapeutic principle presented here shall be compared in a randomized and extended fashion with a conventional therapeutic approach.
在一项针对后颅窝髓母细胞瘤患儿的合作性2期研究中,应用了在手术和放疗期间进行强化多药化疗的原则。在这项现已开展1年零10个月的研究之后,对47名登记患者中的33名进行了首次评估。在大多数患者中,化疗方案能够完全实施,没有任何减项。分析了包括两例与治疗相关的死亡在内的副作用。所有患者的放疗均未延迟,术后约11周即可开始,且进行过程中没有任何重大问题。由于研究时间较短,生存分析只能是初步的,但患者的生存情况与其他报道的研究结果相符。本文提出的治疗原则应与传统治疗方法进行随机对照和扩大样本的比较。